ストックスクリーナーアプリを入手
41.70
0.02%
0.01
アフターアワーズ：
41.70
前日終値:
$41.69
開ける：
$41.23
24時間の取引高:
1.16M
Relative Volume:
1.10
時価総額：
$3.28B
収益：
$399.58M
当期純損益:
$-54.04M
株価収益率:
-55.60
EPS:
-0.75
ネットキャッシュフロー:
$40.13M
1週間 パフォーマンス:
+15.58%
1か月 パフォーマンス:
+20.49%
6か月 パフォーマンス:
+35.21%
1年 パフォーマンス:
+11.68%
1日の値動き範囲:
$39.95
$41.90
1週間の範囲:
$35.26
$46.44
52週間の値動き範囲:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
41.70 | 3.30B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
572.41 | 212.64B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
209.94 | 148.81B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
708.45 | 56.99B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.74 | 41.81B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.46 | 35.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | 開始されました | Canaccord Genuity | Hold |
| 2025-03-20 | 開始されました | Craig Hallum | Buy |
| 2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-16 | 開始されました | UBS | Buy |
| 2024-10-10 | 開始されました | Guggenheim | Buy |
| 2024-02-23 | 繰り返されました | Needham | Buy |
| 2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2021-11-18 | 再開されました | Goldman | Buy |
| 2021-06-15 | 開始されました | Raymond James | Outperform |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 開始されました | Morgan Stanley | Underweight |
| 2019-07-31 | 開始されました | Lake Street | Buy |
| 2019-07-02 | 開始されました | Needham | Buy |
| 2018-11-29 | ダウングレード | Janney | Buy → Neutral |
| 2018-10-31 | アップグレード | Janney | Neutral → Buy |
| 2017-11-07 | ダウングレード | Janney | Buy → Neutral |
| 2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 再開されました | BTIG Research | Buy |
| 2016-11-14 | 再開されました | Leerink Partners | Outperform |
| 2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
| 2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
Can Veracyte Inc. (12V) stock ride next bull market cycleGlobal Markets & Detailed Earnings Play Alerts - newser.com
Insider Sell Alert: Karin Eastham Sells 9,674 Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte Inc. (VCYT) Stock Price | Live Quotes & Charts | NSD - StocksToTrade
Veracyte (VCYT) Gains Favor in Updated Prostate Cancer Guidelines - GuruFocus
NCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim - TipRanks
How to read the order book for Veracyte Inc.2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Short interest data insights for Veracyte Inc.2025 Volume Leaders & Community Verified Watchlist Alerts - newser.com
What to do if you’re stuck in Veracyte Inc.July 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Heatmap analysis for Veracyte Inc. and competitors2025 Dividend Review & Short-Term High Return Ideas - newser.com
How Veracyte Inc. stock performs in interest rate cyclesChart Signals & Safe Entry Point Alerts - newser.com
Using portfolio simulators with Veracyte Inc. included2025 Market Overview & Growth Focused Investment Plans - newser.com
Technical analysis overview for Veracyte Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
How Veracyte Inc. stock reacts to job market data2025 Market Outlook & Technical Pattern Alert System - newser.com
Veracyte (Nasdaq: VCYT) will webcast investor conference presentations with 90-day replays - Stock Titan
Veracyte to Participate in Upcoming Investor Conferences - Business Wire
Veracyte, Inc. (NASDAQ:VCYT) Q3 2025 Earnings Call Transcript - Insider Monkey
Can swing trading help recover from Veracyte Inc. lossesWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Tools to assess Veracyte Inc.’s risk profile2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
Will Veracyte Inc. stock benefit from commodity pricesJuly 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
How Veracyte Inc. stock performs in rising dollar environmentJuly 2025 Patterns & Stock Portfolio Risk Management - newser.com
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Veracyte (VCYT) Turns Profitable, But Significant $27M Loss Challenges Bullish Narratives - Yahoo Finance
Veracyte (VCYT) Q3 Earnings and Revenues Beat Estimates - sharewise.com
Is Veracyte Inc. (12V) stock cheap vs fundamentalsTake Profit & Weekly High Conviction Trade Ideas - newser.com
Veracyte Inc. Reports Robust Q3 Earnings Performance - TipRanks
UBS Raises Price Target for Veracyte (VCYT) to $48, Maintains Bu - GuruFocus
Veracyte Inc earnings beat by $0.19, revenue topped estimates - Investing.com Australia
Veracyte (NASDAQ:VCYT) Announces Quarterly Earnings Results, Beats Estimates By $0.19 EPS - MarketBeat
Veracyte raises 2025 revenue outlook to $510M while accelerating double-digit growth investments - MSN
Veracyte (VCYT): Analyst Raises Price Target Amidst Stable Ratin - GuruFocus
Needham raises Veracyte stock price target to $44 on strong growth outlook - Investing.com Philippines
Veracyte (VCYT) Shares Surge Over 21% in Market Rally - GuruFocus
Veracyte’s Q3 Earnings Soar Past Expectations, Stock Climbs - StocksToTrade
Veracyte, Inc. Experiences Evaluation Adjustment Amid Competitive Market Landscape - Markets Mojo
Veracyte’s Q3 Earnings Beat Estimates Amid Revenue Forecast Increase - timothysykes.com
Veracyte (VCYT) Shares Jump Over 26% Following Market Activity - GuruFocus
Veracyte (VCYT) Analyst Rating Update: Guggenheim Raises Price T - GuruFocus
Why Veracyte Inc. (12V) stock is a strong analyst pickJuly 2025 Decliners & AI Driven Price Forecasts - fcp.pa.gov.br
UBS Adjusts Price Target on Veracyte to $48 From $42, Maintains Buy Rating - MarketScreener
VERACYTE, INC. SEC 10-Q Report - TradingView
[10-Q] VERACYTE, INC. Quarterly Earnings Report | VCYT SEC FilingForm 10-Q - Stock Titan
Canaccord raises Veracyte stock price target to $43 on improved margins By Investing.com - Investing.com South Africa
Canaccord raises Veracyte stock price target to $43 on improved margins - Investing.com India
Cathie Wood Offloads Millions of Biotech Shares, Ramps Stake in Veracyte Days Before Earnings Beat - inkl
Needham raises Veracyte stock price target to $44 on strong growth outlook By Investing.com - Investing.com Nigeria
Veracyte Q3 2025 Earnings Call Transcript - MarketBeat
Veracyte (VCYT) Price Target Raised by Needham Analyst | VCYT St - GuruFocus
Chart based analysis of Veracyte Inc. trends2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.02%
大文字化:
|
ボリューム (24 時間):